Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Elke, Firat"'
Autor:
Kateryna Onyshchenko, Ren Luo, Elena Guffart, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/9611116748194752b53637c4fb8e26f4
Autor:
Kateryna Onyshchenko, Ren Luo, Elena Guffart, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Combination of radiation therapy (RT) with immune checkpoint blockade can enhance systemic anti-tumor T cell responses. Here, using two mouse tumor models, we demonstrate that adding long-acting CD122-directed IL-2 complexes (IL-2c) to RT/an
Externí odkaz:
https://doaj.org/article/f9e6a4f9f7cc441cbb1bcc250a712ba3
Autor:
Eleni Gkika, Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Popp, Gianluca Radicioni, Simon S. Lo, Ursula Nestle, Nils H. Nicolay, Gabriele Niedermann, Dan G. Duda, Anca-L. Grosu
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-6 (2023)
Abstract We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8+ cytotoxic T lymphocytes at first follow-up (the primar
Externí odkaz:
https://doaj.org/article/537504b77a584db7a48979724411a17a
Autor:
Simone Gaedicke, Elke Firat, Gabriele Niedermann, Liqun Wang, Ren Luo, Kateryna Onyshchenko, Xi Rao, Meidan Wang, Beatrice Menz, Anca-Ligia Grosu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly d
Externí odkaz:
https://doaj.org/article/133823e568944a20bf45d927283be209
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-16 (2019)
Abstract Background Immunogenic radiotherapy (RT) can act synergistically with immune checkpoint blockers (ICBs). However, alternatives are needed for non-responding patients and those with pre-existing or ICB-induced autoimmune symptoms. Combination
Externí odkaz:
https://doaj.org/article/e457fde1ed04482cb15845f9bd6b08c0
Autor:
Gabriele Niedermann, Elke Firat, Anca-Ligia Grosu, Simone Gaedicke, Liqun Wang, Kateryna Onyshchenko, Ren Luo
Published papers on clinical cohorts/ongoing clinical trials using sequential or concurrent hRT/SBRT and cisplatin or carboplatin-based chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e3a8bd55e9081f768d5622db46a287
https://doi.org/10.1158/1078-0432.22489314
https://doi.org/10.1158/1078-0432.22489314
Autor:
Gabriele Niedermann, Elke Firat, Anca-Ligia Grosu, Simone Gaedicke, Liqun Wang, Kateryna Onyshchenko, Ren Luo
Potency of platinum derivatives to facilitate the RT-induced abscopal effect in the C51 colon carcinoma model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487f343f20bf4f779b9324a987cf9b93
https://doi.org/10.1158/1078-0432.22489353
https://doi.org/10.1158/1078-0432.22489353
Autor:
Gabriele Niedermann, Elke Firat, Anca-Ligia Grosu, Simone Gaedicke, Liqun Wang, Kateryna Onyshchenko, Ren Luo
Purpose:Cisplatin is increasingly used in chemoimmunotherapy and may enhance the T cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is poorly understood. We investigated whether and why cisplatin is immunogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a619b786605e62d98cbe07107f1aae8
https://doi.org/10.1158/1078-0432.c.6532932.v1
https://doi.org/10.1158/1078-0432.c.6532932.v1
Ratio of tumor-specific CD8+ T cells to tumor cells is enhanced upon treatment with cisplatin + anti-PD-1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc0e8bbc2b8cecee214c7116ef6f46f
https://doi.org/10.1158/1078-0432.22471538
https://doi.org/10.1158/1078-0432.22471538
CD8 depletion efficacy in peripheral blood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7526624bf08bec58d83f18c6eb20858c
https://doi.org/10.1158/1078-0432.22471541.v1
https://doi.org/10.1158/1078-0432.22471541.v1